BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20972433)

  • 21. Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1.
    Zweier-Renn LA; Hawley TS; Burkett S; Ramezani A; Riz I; Adler RL; Hickstein DD; Hawley RG
    Genes Chromosomes Cancer; 2010 Feb; 49(2):119-31. PubMed ID: 19862821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
    Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
    Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
    Bergeron J; Clappier E; Radford I; Buzyn A; Millien C; Soler G; Ballerini P; Thomas X; Soulier J; Dombret H; Macintyre EA; Asnafi V
    Blood; 2007 Oct; 110(7):2324-30. PubMed ID: 17609427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
    Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
    Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.
    Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F
    Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643
    [No Abstract]   [Full Text] [Related]  

  • 26. TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.
    Dadi S; Le Noir S; Payet-Bornet D; Lhermitte L; Zacarias-Cabeza J; Bergeron J; Villarèse P; Vachez E; Dik WA; Millien C; Radford I; Verhoeyen E; Cosset FL; Petit A; Ifrah N; Dombret H; Hermine O; Spicuglia S; Langerak AW; Macintyre EA; Nadel B; Ferrier P; Asnafi V
    Cancer Cell; 2012 Apr; 21(4):563-76. PubMed ID: 22516263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells.
    Heidari M; Rice KL; Phillips JK; Kees UR; Greene WK
    Leukemia; 2006 Feb; 20(2):304-12. PubMed ID: 16357834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
    Verboom K; Van Loocke W; Volders PJ; Decaesteker B; Cobos FA; Bornschein S; de Bock CE; Atak ZK; Clappier E; Aerts S; Cools J; Soulier J; Taghon T; Van Vlierberghe P; Vandesompele J; Speleman F; Durinck K
    Haematologica; 2018 Dec; 103(12):e585-e589. PubMed ID: 29954933
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.
    Mets E; Van der Meulen J; Van Peer G; Boice M; Mestdagh P; Van de Walle I; Lammens T; Goossens S; De Moerloose B; Benoit Y; Van Roy N; Clappier E; Poppe B; Vandesompele J; Wendel HG; Taghon T; Rondou P; Soulier J; Van Vlierberghe P; Speleman F
    Leukemia; 2015 Apr; 29(4):798-806. PubMed ID: 25231743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.
    Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP
    Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells.
    Dixon DN; Izon DJ; Dagger S; Callow MJ; Taplin RH; Kees UR; Greene WK
    Br J Haematol; 2007 Jul; 138(1):54-67. PubMed ID: 17555447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress.
    Foijer F; Xie SZ; Simon JE; Bakker PL; Conte N; Davis SH; Kregel E; Jonkers J; Bradley A; Sorger PK
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13427-32. PubMed ID: 25197064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
    Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
    Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.
    Riz I; Hawley RG
    Oncogene; 2005 Aug; 24(36):5561-75. PubMed ID: 15897879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A promoter with bidirectional activity is located between TLX1/HOX11 and a divergently transcribed novel human gene.
    Greene WK; Sontani Y; Sharp MA; Dunn DS; Kees UR; Bellgard MI
    Gene; 2007 Apr; 391(1-2):223-32. PubMed ID: 17303350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
    Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
    Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors.
    Riz I; Lee HJ; Baxter KK; Behnam R; Hawley TS; Hawley RG
    Biochem Biophys Res Commun; 2009 Mar; 380(2):361-5. PubMed ID: 19250647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.